George C. Prendergast
George C. Prendergast (born 1961) is an American biomedical scientist. His research has focused on cancer pathobiology and immunology. Since 2004, he has been the President and CEO of Lankenau Institute for Medical Research, a cancer-focused research center in the U.S. He is also the co-director of the Program in Cancer Cell Biology & Signaling at the Sidney Kimmel Cancer Center, Thomas Jefferson University.
George C. Prendergast | |
|---|---|
| Born | Philadelphia, Pennsylvania |
| Alma mater | Princeton University Yale University University of Pennsylvania |
| Awards | 1995 Pew Scholar in the Biomedical Sciences |
| Scientific career | |
| Fields | Oncology, Molecular biology, Oncoimmunology |
| Institutions | Lankenau Institute for Medical Research DuPont Pharmaceuticals Company The Wistar Institute Merck Research Laboratories Howard Hughes Medical Institute |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.